Atlanta Braves Holdings, Inc. (BATRK)
시가총액: 2.54B
국가: United States
산업: #Services_Misc_Amusement_and_Recreation
섹터: #Consumer_Discretionary
홈페이지: https://www.bravesholdings.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 47.21M / 31.00M / 52.3% / 27.3% / -9.4%
2412: 52.12M / 68.50M / -23.9% / -23.1% / -82.1%
2409: 290.67M / 273.20M / 6.4% / 6.9% / 2.8%
2406: 282.88M / 281.70M / 0.4% / 4.7% / 662.9%
2403: 37.08M / -- / -- / 19.7% / -45.3%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.66 / -- / -- / 20.5% / -112.9%
2412: -0.31 / -0.19 / -63.2% / -- / -293.7%
2409: 0.16 / 0.1 / 60.0% / 260.0% / -65.2%
2406: 0.46 / 0.34 / 35.3% / 184.5% / 155.4%
2403: -0.83 / -- / -- / 11.7% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 640.67M(8.9%) / -2.03(-269.1%)
2212: 588.56M(3.6%) / -0.55(-163.9%)
2112: 568.0M(219.1%) / -0.208374(89.6%)
2012: 178.0M(--) / -2.0(--)

#BATRK

- 사업요약: Atlanta Braves Holdings, Inc., through its subsidiary, Braves Holdings, LLC, owns and operates the Atlanta Braves Major League Baseball Club. It als...

Seadrill Limited (SDRL)
시가총액: 1.49B
국가:
산업: #Oil_and_Gas_Production
섹터: #Energy
홈페이지: https://www.seadrill.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 335M / 340.43M / -1.6% / -8.7% / 15.9%
2412: 289M / 300.56M / -3.8% / -29.2% / -18.4%
2409: 354M / 326.7M / 8.4% / -14.5% / -5.6%
2406: 375M / 357.41M / 4.9% / -9.4% / 2.2%
2403: 367.0M / -- / -- / 38.0% / -10.0%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.23 / 0.3935 / -158.4% / -128.4% / -114.9%
2412: 1.54 / -0.3891 / 495.8% / -- / 214.3%
2409: 0.49 / 0.0615 / 696.7% / -55.5% / -86.0%
2406: 3.49 / 0.5922 / 489.3% / 200.9% / 330.9%
2403: 0.81 / -- / -- / -2.4% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 1.5B(--) / 4.12(--)
2112: 907.0M(-5.6%) / -5.85(93.7%)
2012: 961.0M(-30.8%) / -93.18(-282.2%)
1912: 1.39B(--) / -24.38(--)

#SDRL

- 사업요약: Seadrill Limited provides offshore contract drilling services to the oil and gas industry worldwide. The company owns and operates drill ships, semi-submersible rigs, and jack-up rigs for operations in shallow and ultr...

Blade Air Mobility, Inc. (BLDE)
시가총액: 277.85M
국가: United States
산업: #Transportation_Services
섹터: #Consumer_Discretionary
홈페이지: https://www.blade.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 54.31M / 49.44M / 9.9% / 5.4% / -0.1%
2412: 54.36M / 51.54M / 5.5% / 14.5% / -27.4%
2409: 74.88M / 74.43M / 0.6% / 4.8% / 10.2%
2406: 67.95M / 63.12M / 7.7% / 11.4% / 31.9%
2403: 51.51M / -- / -- / 13.8% / 8.5%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.04 / -0.12 / 66.7% / 33.3% / 65.2%
2412: -0.1148 / -0.1151 / 0.3% / -- / -282.7%
2409: -0.03 / -0.0221 / -35.7% / -1003.3% / 80.0%
2406: -0.15 / -0.03 / -400.0% / 11.8% / -150.0%
2403: -0.06 / -- / -- / 57.1% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 225.18M(54.1%) / --(--)
2212: 146.12M(--) / -0.38(--)
2109: 50.53M(115.6%) / -0.571385(29.5%)
2009: 23.43M(--) / -0.81(-89.0%)

#BLDE

- 사업요약: Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat fli...

NeurAxis, Inc. (NRXS)
시가총액: 14.43M
국가:
산업: #Biotechnology_Electromedical_and_Electrotherapeutic_Apparatus
섹터: #Health_Care
홈페이지: https://neuraxis.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 895.66K / -- / -- / 38.5% / --
2412: -- / 3.62M / -- / -- / --
2409: 666.63K / 3.14M / -78.8% / 39.6% / 9.0%
2406: 611.5K / 2.67M / -77.1% / -5.3% / -5.4%
2403: 646.63K / -- / -- / -19.7% / 21.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.33 / -- / -- / -3.1% / --
2412: -- / 0.04 / -- / -- / --
2409: -- / -- / -- / -- / --
2406: -- / -0.05 / -- / -- / --
2403: -0.32 / -- / -- / 9.6% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 2.46M(-8.4%) / -4.5(-398.3%)
2212: 2.68M(-1.3%) / -0.903091(-46.8%)
2112: 2.72M(41.0%) / -0.615127(23.3%)
2012: 1.93M(--) / -0.801721(--)

#NRXS

- 사업요약: NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field ...

Harvard Bioscience, Inc. (HBIO)
시가총액: 15.61M
국가: United States
산업: #Biotechnology_Laboratory_Analytical_Instruments
섹터: #Industrials
홈페이지: https://www.harvardbioscience.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 21.77M / 20M / 8.8% / -11.2% / -11.5%
2412: 24.6M / 24.15M / 1.9% / -12.6% / 12.0%
2409: 21.97M / 23.7M / -7.3% / -13.4% / -4.9%
2406: 23.1M / 26.4M / -12.5% / -19.7% / -5.8%
2403: 24.51M / -- / -- / -18.2% / -12.9%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.01 / -0.01 / 0.0% / 90.9% / -116.7%
2412: 0.06 / 0.05 / 20.0% / -- / 400.0%
2409: -0.02 / 0.02 / -200.0% / 33.3% / --
2406: 0.0 / 0.05 / -100.0% / 100.0% / 100.0%
2403: -0.11 / -- / -- / -1200.0% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 112.25M(-1.0%) / -0.08(65.2%)
2212: 113.33M(-4.7%) / -0.23(-2200.0%)
2112: 118.9M(16.5%) / -0.01(95.0%)
2012: 102.1M(--) / -0.2(--)

#HBIO

- 사업요약: Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and interna...

Imunon, Inc. (IMNN)
시가총액: 11.96M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://imunon.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -- / --
2412: 0.00 / 0.00 / -- / -- / --
2409: 0.00 / -- / -- / -- / --
2406: 0.00 / -- / -- / -- / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.28 / -0.3575 / 21.7% / 46.2% / -12.0%
2412: -0.25 / -0.364 / 31.3% / -- / 26.5%
2409: -0.34 / -0.39 / 12.8% / 8.1% / 33.3%
2406: -0.51 / -0.55 / 7.3% / 16.4% / 1.9%
2403: -0.52 / -- / -- / 23.5% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 0.0(-100.0%) / -2.16(57.1%)
2212: 500000.0(0.0%) / -5.03(-31.3%)
2112: 500000.0(0.0%) / -3.83(62.0%)
2012: 500000.0(--) / -10.08499(--)

#IMNN

- 사업요약: Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatmen...

Lexeo Therapeutics, Inc. (LXEO)
시가총액: 89.3M
국가: United States
산업: #Biotechnology_Biological_Products_No_Diagnostic_Substances
섹터: #Health_Care
홈페이지: https://www.lexeotx.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / -- / -- / -- / --
2412: 0.00 / -- / -- / -- / --
2409: 0.00 / -- / -- / -- / --
2406: 0.00 / -- / -- / -- / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.99 / -0.89 / -11.2% / -28.6% / -26.9%
2412: -0.78 / -0.72 / -8.3% / -- / 12.4%
2409: -0.89 / -0.72 / -23.6% / -11.4% / -39.1%
2406: -0.64 / -0.77 / 16.9% / -19.8% / 16.9%
2403: -0.77 / -- / -- / -3.9% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 0.0(-100.0%) / -12.4(-426.5%)
2212: 654000.0(-60.5%) / -2.355128(-17.1%)
2112: 1.66M(219.6%) / -2.011258(-882.4%)
2012: 518476.0(--) / -0.204725(--)

#LXEO

- 사업요약: Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candida...

Akero Therapeutics, Inc. (AKRO)
시가총액: 3.30B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://akerotx.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -- / --
2412: 0.00 / 0.00 / -- / -- / --
2409: 0.00 / 0.00 / -- / -- / --
2406: 0.00 / -- / -- / -- / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.9 / -1.01 / 10.9% / 0.0% / 9.1%
2412: -0.99 / -1.16 / 14.7% / -- / 5.7%
2409: -1.05 / -0.8783 / -19.5% / -47.9% / -29.6%
2406: -0.81 / -0.83 / 2.4% / -35.0% / 10.0%
2403: -0.9 / -- / -- / -63.6% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 0.0(--) / -2.89(-0.7%)
2212: 0.0(--) / -2.87(0.7%)
2112: 0.0(--) / -2.89(-14.7%)
2012: 0.0(--) / -2.52(--)

#AKRO

- 사업요약: Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that pr...

Metsera, Inc. (MTSR)
시가총액: 2.51B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / -- / -- / -- / --
2412: 0.00 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -1.03 / -- / -- / -- / 70.7%
2412: -3.52 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#MTSR

- 사업요약:

Sionna Therapeutics, Inc. (SION)
시가총액: 543.61M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / -- / -- / -- / --
2412: 0.00 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.62 / -- / -- / -- / 81.7%
2412: -3.38 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#SION

- 사업요약: